⌘K
Loading ticker…
As of 2026-08-24, Aktis Oncology, Inc. Common stock (AKTS) has a 3-month relative strength percentile of 87 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.9%, relative volume 3.19×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
AKTS is held by 11 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $4M.
Held by 18 ETFs · $30M across latest filings · largest weight 0.24% (TMED).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.01% | $2M | +0.01 pp |
| SCHASchwab U.S. Small-Cap ETF | 0.01% | $2M | new |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $289K | new |
| VTWG | 0.01% | $209K | +0.01 pp |
| VTWV | 0.01% | $158K | +0.01 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $36K |
| — |
| ITWO | 0.01% | $20K | new |
| URTY | 0.00% | $16K | new |
| UWM | 0.01% | $16K | new |
| HDG | 0.00% | $394 | new |
Showing 10 of 11 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AKTS Jan avg: 18111.70% median: 30.85% win: 67% σ: 31370.73% n: 3 2022-04-12 → 2026-07-31 | AKTS Feb avg: 3.06% median: 1.35% win: 67% σ: 4.74% n: 3 2022-04-12 → 2026-07-31 | AKTS Mar avg: -11.24% median: -11.13% win: 0% σ: 6.36% n: 3 2022-04-12 → 2026-07-31 | AKTS Apr avg: -6.33% median: -4.07% win: 25% σ: 11.57% n: 4 2022-04-12 → 2026-07-31 | AKTS May avg: -12.95% median: 0.35% win: 50% σ: 35.00% n: 4 2022-04-12 → 2026-07-31 | AKTS Jun avg: 2.45% median: -3.43% win: 50% σ: 39.17% n: 4 2022-04-12 → 2026-07-31 | AKTS Jul avg: -12.28% median: -16.64% win: 25% σ: 21.01% n: 4 2022-04-12 → 2026-07-31 | AKTS Aug avg: -22.50% median: -33.00% win: 33% σ: 21.59% n: 3 2022-04-12 → 2026-07-31 (current) | AKTS Sep avg: -23.86% median: -32.19% win: 33% σ: 31.30% n: 3 2022-04-12 → 2026-07-31 | AKTS Oct avg: -19.36% median: -32.66% win: 33% σ: 27.37% n: 3 2022-04-12 → 2026-07-31 | AKTS Nov avg: 35.80% median: 14.11% win: 100% σ: 39.03% n: 3 2022-04-12 → 2026-07-31 | AKTS Dec avg: -14.23% median: -25.79% win: 33% σ: 55.67% n: 3 2022-04-12 → 2026-07-31 |